Smart messages and alerts for an infusion delivery and management system

• US 10,448,834 B2
• Filed: 10/05/2017
• Issued: 10/22/2019
• Est. Priority Date: 02/28/2006
• Status: Active Grant

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Inventors: Jennewine, R. Curtis, Krapek, Kimberley J.
• Primary Examiner(s): Berhanu, Etsub D
• Application Number:
  US15/725,474
• Publication Number:
  US 20180055363A1
• Time in Patent Office: 747 Days
• Field of Search: None
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment

Abstract

Method and system for providing diabetes management is provided.

Claims

1. A method of preventing nocturnal hypoglycemia with an analyte monitoring system, the method comprising:

detecting, by a first electronic device of the analyte monitoring system, a pre-sleep time period comprising a time period prior to when a user enters a sleep cycle, wherein the first electronic device enters a pre-sleep mode in response thereto;

performing, by the first electronic device, the following steps without user input, during the pre-sleep time period;

receiving, from a second electronic device of the analyte monitoring system, a predetermined number of consecutive analyte level readings for the pre-sleep time period, wherein the predetermined number of consecutive analyte level readings includes two or more consecutive analyte level readings;

comparing each of the predetermined number of consecutive analyte level readings for the pre-sleep time period to a target analyte level for the pre-sleep time period; and

exiting, by the first electronic device, the pre-sleep mode and waiting for a subsequent pre-sleep time period in response to a first threshold number of the predetermined number of consecutive analyte level readings being greater than the target analyte level.

2. The method of claim 1, further comprising:

generating and outputting an alert in response to a second threshold number of the predetermined number of consecutive analyte level readings being equal to or lower than the target analyte level.

3. The method of claim 2, further comprising outputting the alert to the first electronic device, wherein the first electronic device comprises a medication delivery unit.

4. The method of claim 3, wherein the medication delivery unit includes an insulin pump.

5. The method of claim 3, further comprising wirelessly communicating with the medication delivery unit over a radio frequency (RF) communication link, a Bluetooth communication link, an Infrared communication link, or a local area network (LAN).

6. The method of claim 2, wherein the alert includes one or more of an audible alert, a visual alert, or a tactile alert.

7. The method of claim 6, wherein the visual alert includes one or more of an alphanumeric output display, a graphical output display, an icon display, a video output display, a color display, or an illumination display.

8. The method of claim 2, wherein the alert includes generating a recommendation that the user ingest a snack or modify a basal rate delivery of insulin.

9. The method of claim 1, further comprising programming the pre-sleep time mode to define a pre-sleep time period by specifying a user-specific meal or sleep schedule.

10. The method of claim 1, wherein the pre-sleep time period begins at approximately a predetermined number of hours after the last meal of the day, and terminates at the beginning of entering the sleep cycle.

11. The method of claim 1, wherein the first electronic device is a medication delivery unit and the second electronic device is an analyte monitoring device.

12. A method of preventing nocturnal hypoglycemia with an analyte monitoring system, the method comprising:

programming a first electronic device of the analyte monitoring system with a pre-sleep mode to define a pre-sleep time period by specifying a user-specific meal or sleep schedule;

detecting, by the first electronic device, the pre-sleep time period, wherein the first electronic device enters the pre-sleep mode in response thereto;

performing, by the first electronic device, the following steps, without user input, during the pre-sleep time period;

receiving, from a second electronics device of the analyte monitoring system, a predetermined number of consecutive analyte level readings for the pre-sleep time period, wherein the predetermined number of consecutive analyte level readings includes two or more consecutive analyte level readings;

comparing each of the predetermined number of consecutive analyte level readings for the pre-sleep time period to a target analyte level for the pre-sleep time period;

exiting by the first electronic device, the pre-sleep mode and waiting for a subsequent pre-sleep time period in response to a first threshold number of the predetermined number of consecutive analyte level readings being greater than the target analyte level; and

generating and outputting an alert in response to a second threshold number of the predetermined number of consecutive analyte level readings being equal to or lower than the target analyte level.

13. The method of claim 12, further comprising outputting the alert to the first electronics device, wherein the first electronic device comprises a medication delivery unit.

14. The method of claim 13, wherein the medication delivery unit includes an insulin pump.

15. The method of claim 13, further comprising wirelessly communicating with the medication delivery unit over a radio frequency (RF) communication link, a Bluetooth communication link, an Infrared communication link, or a local area network (LAN).

16. The method of claim 12, wherein the alert includes one or more of an audible alert, a visual alert, or a tactile alert.

17. The method of claim 16, wherein the visual alert includes one or more of an alphanumeric output display, a graphical output display, an icon display, a video output display, a color display, or an illumination display.

18. The method of claim 12, wherein the alert includes generating a recommendation that the user ingest a snack or modify a basal rate delivery of insulin.

19. The method of claim 12, wherein the pre-sleep time period comprises a time period prior to when a user enters a sleep cycle, and wherein the pre-sleep time period begins at approximately a predetermined number of hours after the last meal of the day, and terminates at the beginning of entering the sleep cycle.

20. The method of claim 12, wherein the first electronic device is a medication delivery unit and the second electronic device is an analyte monitoring device.